Huang D, Wong V, Rinella M, Boursier J, Lazarus J, Yki-Jarvinen H
Nat Rev Dis Primers. 2025; 11(1):14.
PMID: 40050362
DOI: 10.1038/s41572-025-00599-1.
Bezawork-Geleta A, Devereux C, Keenan S, Lou J, Cho E, Nie S
Nat Commun. 2025; 16(1):2135.
PMID: 40032835
PMC: 11876333.
DOI: 10.1038/s41467-025-57405-5.
Hwang S, Stoffel E, Kim D, Verna E, Zhang W
Gastro Hep Adv. 2025; 4(4):100592.
PMID: 39996240
PMC: 11846918.
DOI: 10.1016/j.gastha.2024.100592.
Chen V, Brady G
Hepatol Commun. 2025; 9(1.
PMID: 39774697
PMC: 11717516.
DOI: 10.1097/HC9.0000000000000618.
Huang H, Vitali C, Zhang D, Hand N, Phillips M, Creasy K
JHEP Rep. 2024; 7(1):101243.
PMID: 39687601
PMC: 11647476.
DOI: 10.1016/j.jhepr.2024.101243.
Global Epidemiology of Hepatocellular Carcinoma.
Singh S, Madke T, Chand P
J Clin Exp Hepatol. 2024; 15(2):102446.
PMID: 39659901
PMC: 11626783.
DOI: 10.1016/j.jceh.2024.102446.
Advances in the management of alcohol-associated liver disease.
Anouti A, Kerr T, Mitchell M, Cotter T
Gastroenterol Rep (Oxf). 2024; 12:goae097.
PMID: 39502523
PMC: 11537353.
DOI: 10.1093/gastro/goae097.
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders.
Demirtas C, Yilmaz Y
J Clin Transl Hepatol. 2024; 12(10):857-864.
PMID: 39440221
PMC: 11491501.
DOI: 10.14218/JCTH.2024.00257.
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association study.
Innes H, Buch S, Kendall T, Fallowfield J, Guha I
Liver Int. 2024; 44(12):3260-3273.
PMID: 39425533
PMC: 11586890.
DOI: 10.1111/liv.16114.
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.
Rabiu L, Zhang P, Afolabi L, Saliu M, Dabai S, Suleiman R
J Gastroenterol. 2024; 59(12):1053-1078.
PMID: 39400718
DOI: 10.1007/s00535-024-02157-0.
Integrating PNPLA3 into clinical risk prediction.
Chen V, Vespasiani-Gentilucci U
Liver Int. 2024; 45(3):e16103.
PMID: 39282715
PMC: 11815612.
DOI: 10.1111/liv.16103.
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.
Sookoian S, Rotman Y, Valenti L
Clin Gastroenterol Hepatol. 2024; 22(11):2177-2187.e3.
PMID: 39094912
PMC: 11512675.
DOI: 10.1016/j.cgh.2024.05.052.
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis.
Ismael N, Usmael S, Belay N, Mekonen H, Johannessen A, Orlien S
World J Hepatol. 2024; 16(7):995-1008.
PMID: 39086536
PMC: 11287608.
DOI: 10.4254/wjh.v16.i7.995.
PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality.
Azariadis K, Gatselis N, Lyberopoulou A, Arvaniti P, Zachou K, Gabeta S
J Transl Autoimmun. 2024; 9:100243.
PMID: 38974691
PMC: 11225017.
DOI: 10.1016/j.jtauto.2024.100243.
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver disease.
Kaplan D, Teerlink C, Schwantes-An T, Norden-Krichmar T, DuVall S, Morgan T
Hepatol Commun. 2024; 8(7).
PMID: 38967582
PMC: 11227360.
DOI: 10.1097/HC9.0000000000000487.
Phospholipid Acyltransferases: Characterization and Involvement of the Enzymes in Metabolic and Cancer Diseases.
Korbecki J, Bosiacki M, Pilarczyk M, Gassowska-Dobrowolska M, Jarmuzek P, Szucko-Kociuba I
Cancers (Basel). 2024; 16(11).
PMID: 38893234
PMC: 11171337.
DOI: 10.3390/cancers16112115.
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma.
Maurotti S, Geirola N, Frosina M, Mirarchi A, Scionti F, Mare R
Front Cell Dev Biol. 2024; 12:1404006.
PMID: 38818407
PMC: 11137176.
DOI: 10.3389/fcell.2024.1404006.
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.
Moore M, Wang X, Kennelly J, Shi H, Ishino Y, Kano K
Hepatology. 2024; 81(2):576-590.
PMID: 38776184
PMC: 11822724.
DOI: 10.1097/HEP.0000000000000933.
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment.
Feng F, Zhao Y
Med Princ Pract. 2024; 33(5):414-423.
PMID: 38772352
PMC: 11460940.
DOI: 10.1159/000539349.
The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.
Leahy C, Osborne N, Shirota L, Rote P, Lee Y, Song B
Biochem Pharmacol. 2024; 228:116241.
PMID: 38697309
PMC: 11774579.
DOI: 10.1016/j.bcp.2024.116241.